Citation Impact
Citing Papers
PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity
2018
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells
2010
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
2017
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
2015 StandoutNobel
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Psoriasis
2014
Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
2012
Innate Lymphoid Cells in Inflammation and Immunity
2014
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
2019
Clinical improvement in psoriasis with specific targeting of interleukin-23
2015 Nature
The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing
2014
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
2016
Single-cell sequencing of human white adipose tissue identifies new cell states in health and obesity
2021
Generation of improved humanized mouse models for human infectious diseases
2014
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor
2014
Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
2020
Clinical lessons learned from the first leg of the CAR T cell journey
2019
SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors
2017
A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling
2013
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Hepatocellular carcinoma
2021 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
Psoriasis
2021 Standout
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
2018
Interaction between microbiota and immunity in health and disease
2020 Standout
A Rapamycin-Activated Caspase 9-Based Suicide Gene
2018
Delivery technologies for cancer immunotherapy
2019 Standout
Engineered T cells: the promise and challenges of cancer immunotherapy
2016
Neutrophil extracellular traps in immunity and disease
2017 Standout
Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma
2016
Foxp3: a genetic foundation for regulatory T cell differentiation and function
2020 StandoutNobel
CAR T‐cell immunotherapy: The path from the by‐road to the freeway?
2015
Engineering CAR-T cells: Design concepts
2015
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
OX40, OX40L and Autoimmunity: a Comprehensive Review
2015
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
The origins and functions of dendritic cells and macrophages in the skin
2014
Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data
2016
The Multitasking Organ: Recent Insights into Skin Immune Function
2011
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
2019
Neutrophils in cancer: neutral no more
2016 Standout
Defining trained immunity and its role in health and disease
2020 Standout
De novo design of tyrosine and serine kinase-driven protein switches
2021 StandoutNobel
New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression
2020 StandoutNobel
Improving the safety of cell therapy products by suicide gene transfer
2014
The biology of innate lymphoid cells
2015 Nature
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Treg cell-based therapies: challenges and perspectives
2019
Control of adaptive immunity by the innate immune system
2015 Standout
CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
2022
Inflammatory memory sensitizes skin epithelial stem cells to tissue damage
2017 Nature
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
Innate Lymphoid Cells in Tumor Immunity
2016
The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps
2015
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Ultraviolet B–Induced Maturation of CD11b-Type Langerin− Dendritic Cells Controls the Expansion of Foxp3+ Regulatory T Cells in the Skin
2017 StandoutNobel
Adoptive cellular therapy: A race to the finish line
2015
Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a
2016
Psoriasis Pathogenesis and Treatment
2019 Standout
Immunology of Psoriasis
2014 Standout
Protein kinase A–dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1
2016 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanovaccines for cancer immunotherapy
2019
Chimeric Antigen Receptor Therapy
2018 Standout
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
2015
Wound Healing: A Cellular Perspective
2018 Standout
Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies
2014
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality
2013
Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells
2019
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia
2017
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Dichotomous regulation of group 3 innate lymphoid cells by nongastric Helicobacter species
2019
The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy
2017
Autocrine/paracrine TGF-β1 inhibits Langerhans cell migration
2012
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
2013
Targeting dendritic cells—why bother?
2013
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
2016
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
Works of Barry Flutter being referenced
Neuroblastoma Killing Properties of Vδ2 and Vδ2-Negative γδT Cells Following Expansion by Artificial Antigen-Presenting Cells
2014
Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
2013
Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor
2017
Nonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation
2010
Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory Phenotype
2012
Calreticulin maintains the low threshold of peptide required for efficient antigen presentation
2009
COMBODY: one‐domain antibody multimer with improved avidity
2010
TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis
2013
Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin
2011
Abstract CT145: A Cancer Research UK phase I trial of anti-GD2 chimeric antigen receptor (CAR) transduced T-cells (1RG-CART) in patients with relapsed or refractory neuroblastoma
2018
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
2014
MHC class I antigen presentation--recently trimmed and well presented.
2004
OX40- and CD27-Mediated Costimulation Synergizes with Anti–PD-L1 Blockade by Forcing Exhausted CD8+ T Cells To Exit Quiescence
2014
The Host Environment Regulates the Function of CD8+ Graft-versus-Host-Reactive Effector Cells
2008